2,6-dichloroindophenol has been researched along with Hemoglobinopathies in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Paritpokee, N; Suwansaksri, J; Wiwanitkit, V | 1 |
Sangkitporn, S; Sangnoi, A; Supangwiput, O; Tanphaichitr, VS | 1 |
2 other study(ies) available for 2,6-dichloroindophenol and Hemoglobinopathies
Article | Year |
---|---|
Combined one-tube osmotic fragility (OF) test and dichlorophenol-indolphenol (DCIP) test screening for hemoglobin disorders, an experience in 213 Thai pregnant women.
Topics: 2,6-Dichloroindophenol; beta-Thalassemia; Electrophoresis, Cellulose Acetate; Female; Hematologic Tests; Hemoglobin E; Hemoglobinopathies; Hemoglobins, Abnormal; Humans; Mass Screening; Osmotic Fragility; Predictive Value of Tests; Pregnancy; Sensitivity and Specificity; Thailand | 2002 |
Validation of osmotic fragility test and dichlorophenol indophenol precipitation test for screening of thalassemia and Hb E.
Topics: 2,6-Dichloroindophenol; Genetic Testing; Hematologic Tests; Hemoglobin E; Hemoglobinopathies; Heterozygote; Humans; Mass Screening; Polymerase Chain Reaction; Predictive Value of Tests; Sequence Analysis, DNA; Thalassemia | 2005 |